Search research articles
Contact Us
Filters
Showing results (31-40 of 51) with videos related to
Page
of 6
Sort By:
Frontiers in Immunology
|
June 23, 2025
Lymphocyte exhaustion in hepatocellular carcinoma: a dynamic evolution across disease stages
Carla Fuster-Anglada, Josep Corominas, Aida Marsal, et al.
Cancer Research
|
February 20, 2003
Identification of novel tumor markers in hepatitis C virus-associated hepatocellular carcinoma
Maria W Smith, Zhaoxia N Yue, Gary K Geiss, et al.
Frontiers in Immunology
|
February 23, 2026
Correction: Lymphocyte exhaustion in hepatocellular carcinoma: a dynamic evolution across disease stages
Carla Fuster-Anglada, Josep Corominas, Aida Marsal, et al.
Cancers
|
May 14, 2022
DNA Methylation Regulates a Set of Long Non-Coding RNAs Compromising Hepatic Identity during Hepatocarcinogenesis
Miriam Recalde, María Gárate-Rascón, José María Herranz, et al.
Hepatology (Baltimore, Md.)
|
October 17, 2015
Akt-mediated foxo1 inhibition is required for liver regeneration
Montse Pauta, Noemi Rotllan, Ana Fernández-Hernando, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
December 23, 2023
Sensitization of cholangiocarcinoma cells to chemotherapy through BCRP inhibition with β-caryophyllene oxide
Sara Ortiz-Rivero, Ana Peleteiro-Vigil, Lorena Abete, et al.
United European Gastroenterology Journal
|
July 6, 2021
Early diarrhoea under sorafenib as a marker to consider the early migration to second-line drugs
Álvaro Díaz-González, Víctor Sapena, Loreto Boix, et al.
World Journal of Hepatology
|
September 26, 2022
Polymorphism AGT2 (rs4762) is involved in the development of dermatologic events: Proof-of-concept in hepatocellular carcinoma patients treated with sorafenib
Víctor Sapena, Massimo Iavarone, Loreto Boix, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
October 6, 2020
Pharmacokinetics and pharmacogenetics of sorafenib in patients with hepatocellular carcinoma: Implications for combination trials
Álvaro Díaz-González, Víctor Sapena, Loreto Boix, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
March 12, 2013
A DNA methylation signature associated with the epigenetic repression of glycine N-methyltransferase in human hepatocellular carcinoma
Covadonga Huidobro, Estela G Toraño, Agustín F Fernández, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 51) with videos related to
Sort By:
Page
of 6
Frontiers in Immunology
|
June 23, 2025
Lymphocyte exhaustion in hepatocellular carcinoma: a dynamic evolution across disease stages
Carla Fuster-Anglada, Josep Corominas, Aida Marsal, et al.
Cancer Research
|
February 20, 2003
Identification of novel tumor markers in hepatitis C virus-associated hepatocellular carcinoma
Maria W Smith, Zhaoxia N Yue, Gary K Geiss, et al.
Frontiers in Immunology
|
February 23, 2026
Correction: Lymphocyte exhaustion in hepatocellular carcinoma: a dynamic evolution across disease stages
Carla Fuster-Anglada, Josep Corominas, Aida Marsal, et al.
Cancers
|
May 14, 2022
DNA Methylation Regulates a Set of Long Non-Coding RNAs Compromising Hepatic Identity during Hepatocarcinogenesis
Miriam Recalde, María Gárate-Rascón, José María Herranz, et al.
Hepatology (Baltimore, Md.)
|
October 17, 2015
Akt-mediated foxo1 inhibition is required for liver regeneration
Montse Pauta, Noemi Rotllan, Ana Fernández-Hernando, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
December 23, 2023
Sensitization of cholangiocarcinoma cells to chemotherapy through BCRP inhibition with β-caryophyllene oxide
Sara Ortiz-Rivero, Ana Peleteiro-Vigil, Lorena Abete, et al.
United European Gastroenterology Journal
|
July 6, 2021
Early diarrhoea under sorafenib as a marker to consider the early migration to second-line drugs
Álvaro Díaz-González, Víctor Sapena, Loreto Boix, et al.
World Journal of Hepatology
|
September 26, 2022
Polymorphism AGT2 (rs4762) is involved in the development of dermatologic events: Proof-of-concept in hepatocellular carcinoma patients treated with sorafenib
Víctor Sapena, Massimo Iavarone, Loreto Boix, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
October 6, 2020
Pharmacokinetics and pharmacogenetics of sorafenib in patients with hepatocellular carcinoma: Implications for combination trials
Álvaro Díaz-González, Víctor Sapena, Loreto Boix, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
March 12, 2013
A DNA methylation signature associated with the epigenetic repression of glycine N-methyltransferase in human hepatocellular carcinoma
Covadonga Huidobro, Estela G Toraño, Agustín F Fernández, et al.
Page
of 6